Catalyst
Slingshot members are tracking this event:
Phase 3 presentation of Actinium Pharma's(ATNM) Iomab-B in Hematopoietic Stem Cells Transplantation expected at ASCO
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ATNM | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 04, 2019
Occurred Source:
https://ir.actiniumpharma.com/press-releases/detail/332/actinium-presents-new-pivotal-phase-3-sierra-trial-data
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Iomab-b, Asco 2019, Hematopoietic Stem Cell Transplantation
